


Ask a doctor about a prescription for Rosucard
Rosuvastatinum
Rosucard belongs to a group of medicines called statins.
The doctor has prescribed a statin because diet changes and increased physical activity have proven insufficient to achieve normal cholesterol levels in the blood. The patient taking Rosucard should also follow a low-cholesterol diet and exercise regularly. Alternatively,
Heart attack, stroke, and other problems can be caused by atherosclerosis of the arteries. Atherosclerosis of the arteries is the result of the deposition of atherosclerotic plaques in the blood vessels.
Rosucard is used to achieve normal levels of fatty substances in the blood, called lipids. The most common of these is cholesterol. There are different types of cholesterol in the blood, so-called "bad" cholesterol (LDL-C) and "good" cholesterol (HDL-C).
Page 1 of 8
In most people, increased cholesterol levels do not change their well-being, as they do not cause any symptoms. However, if the patient does not receive treatment, fatty deposits accumulate in the walls of blood vessels and their narrowing. Sometimes, the narrowed blood vessel may become blocked, disrupting blood flow to the heart or brain, and consequently leading to a heart attack or stroke. Achieving normal cholesterol levels in the blood reduces the risk of heart attack, stroke, or similar diseases. Even if the cholesterol level is normal after taking Rosucard, the patient should continue to take it. This prevents the cholesterol level from increasing again, which causes the accumulation of fatty substances. The patient should stop taking the medicine if the doctor so advises or if the patient becomes pregnant.
If any of the above situations apply to the patient or the patient has doubts, they should contact their doctor again.
If any of the above situations apply to the patient (or the patient has doubts), they should contact their doctor again.
Before starting to take Rosucard, the patient should consult their doctor or pharmacist:
Page 2 of 8
The patient should immediately contact their doctor if they experience unexplained muscle pains or weaknesses, especially if accompanied by general malaise and fever. The patient should also inform their doctor or pharmacist if they experience persistent muscle weakness,
If any of the above situations apply to the patient (or the patient has doubts):
When to exercise special caution when taking Rosucard:
In connection with the use of Rosucard, severe skin reactions have been reported, including Stevens-Johnson syndrome and drug reaction with eosinophilia and systemic symptoms (DRESS). If any of the symptoms described in section 4 occur, the patient should stop taking Rosucard and seek medical help immediately.
A small group of patients taking statins may experience liver function disorders. To confirm such an effect, a blood test is performed to check liver enzyme activity. Usually, the doctor recommends performing a liver enzyme activity test in the blood before starting and during treatment with Rosucard.
Patients with diabetes or those at risk of developing diabetes will be under close medical supervision while taking this medicine. Patients with high blood sugar and fat levels, overweight, and high blood pressure may be at risk of developing diabetes.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take.
The patient should tell their doctor if they are taking:
If the patient needs to take fusidic acid orally to treat a bacterial infection, they should temporarily stop taking Rosucard. The doctor will inform the patient when they can safely start taking Rosucard again. Taking Rosucard with fusidic acid can rarely lead to muscle weakness, tenderness, or pain (rhabdomyolysis); see the section "Rosucard and other medicines".
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Rosucard should not be taken during pregnancy or breastfeeding. If the patient becomes pregnant while taking Rosucard, they should stop taking it and consult their doctor immediately. Women should avoid becoming pregnant while taking Rosucard, using effective methods of contraception.
Most people can drive and use machines while taking Rosucard
If the patient has previously been found to be intolerant to some sugars, they should consult their doctor before taking this medicine.
This medicine contains less than 1 mmol of sodium (23 mg) per tablet, which means it is considered "sodium-free".
This medicine should always be taken exactly as prescribed by the doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist.
Taking Rosucard to lower cholesterol levels
Initial dose
Treatment should be started with a dose of 5 mg or 10 mg of Rosucard, even if the patient has previously taken higher doses of other statins.
A dose of 5 mg can be obtained by dividing a 10 mg tablet along the marked line.
Page 4 of 8
The size of the initial dose depends on:
The patient should ask their doctor or pharmacist which initial dose of rosuvastatin is most suitable for them.
The doctor may decide to use the smallest dose (5 mg) if:
Increasing the dose and maximum daily dose
The doctor may decide to increase the dose so that it is suitable for the patient's needs.
If the patient started treatment with a dose of 5 mg, the doctor may decide to increase it to 10 mg, then to 20 mg, or to 40 mg if necessary. If the patient started treatment with a dose of 10 mg, the doctor may decide to increase it to 20 mg, then to 40 mg if necessary.
The treatment period with the established dose between each increase is 4 weeks.
The maximum daily dose of Rosucard is 40 mg. It is used in patients with high cholesterol levels and a high risk of heart attack or stroke, in whom a dose of 20 mg was insufficient to lower cholesterol levels.
Taking Rosucard to reduce the risk of heart attack or stroke or similar health problems
The recommended daily dose is 20 mg, but the doctor may decide to reduce it if the patient has the factors described above.
The dose range for children and adolescents is 5 to 20 mg. The doctor may decide to increase the dose of Rosucard so that it is suitable for the patient's needs. The maximum daily dose of Rosucard is 10 mg or 20 mg for children aged 6 to 17 years, depending on the type of disease being treated. The medicine should be taken once a day. Rosucard at a dose of 40 mg should not be used in children.
The tablet should be swallowed whole, with a glass of water.
Rosucard should be taken once a dayat any time, with or without food.
It is recommended to take the medicine at the same time every day to make it easier to remember.
To ensure that cholesterol levels have decreased and are normal, the patient should regularly undergo check-ups and blood tests.
The doctor may decide to increase the dose of Rosucard so that it is suitable for the patient's needs.
In case of taking a higher dose of Rosucard than recommended, the patient should contact their doctor or go to the nearest hospital.
If the patient is in the hospital or is being treated for another illness, they should inform their doctor or other medical staff that they are taking Rosucard.
There is no need to worry; the patient should take the next dose at the usual time. The patient should not take a double dose to make up for the missed dose.
The patient should tell their doctor if they want to stop taking Rosucard. Cholesterol levels may increase again if Rosucard treatment is stopped.
In case of any further doubts about taking this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Rosucard can cause side effects, although not everybody gets them.
It is essential for the patient to know which side effects can occur. They are usually mild and disappear shortly after starting treatment.
The patient should stop taking Rosucard immediately and seek medical helpif they experience the following allergic reactions:
The following side effects have been reported in patients taking rosuvastatin (the active substance of Rosucard):
Page 6 of 8
If the patient experiences any side effects, including those not listed in the leaflet, they should tell their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49-21-301, fax: +48 22 49-21-309, website: https://smz.ezdrowie.gov.pl
By reporting side effects, more information can be collected on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 25°C in the original packaging to protect from light and moisture.
Page 7 of 8
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of Rosucard is rosuvastatin.
One film-coated tablet contains 10 mg of rosuvastatin in the form of rosuvastatin calcium.
Other ingredients are:
Core: lactose monohydrate, microcrystalline cellulose, sodium croscarmellose, colloidal anhydrous silica, magnesium stearate;
Coating: hypromellose 2910/5, macrogol 6000, titanium dioxide (E 171), talc, iron oxide red (E 172).
Pale pink, film-coated, oval, biconvex tablets with a marked line on one side, approximately 8.8 mm long and 4.5 mm wide. The tablet can be divided into equal doses.
Pack size
30, 90 film-coated tablets.
To obtain more detailed information, the patient should contact the marketing authorization holder or the parallel importer.
Zentiva, k. s., U Kabelovny 130, 102 37 Prague 10, Czech Republic
Zentiva, k. s., U Kabelovny 130, 102 37 Prague 10, Czech Republic
S.C. Zentiva S.A., B-dul Theodor Pallady nr.50, sector 3, Bucharest, cod032266 Romania
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź
Parallel import authorization number: 41/22
This medicine is authorized in the Member States of the European Economic Area under the following names:
Bulgaria:
РОСУКАРД
Czech Republic, Estonia, Poland, Romania, Slovakia:
Rosucard
Latvia, Lithuania:
Rosuvacard
Date of leaflet approval: 18.01.2022
[Information about the trademark]
Page 8 of 8
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Rosucard – subject to medical assessment and local rules.